More NewsRead More
Phase 2b TARGET Trial Results Show Improved Survival in Adenocarcinoma Non-Small Cell Lung Cancer Patients Treated With Endocyte's Vintafolide
September 27, 2014
Cybersecurity concerns weigh down markets
September 09, 2014
Endocyte Announces Late-Breaking Abstract Presentation at the European Society for Medical Oncology (ESMO) Conference
September 22, 2014
Notable Analyst Rating Changes 9/30: (AA) (FBC) (SSE) Upgraded; (TIBX) (ECYT) (ARMH) Downgraded
Today 10:24 EDT
Benzinga's Top Downgrades
Today 9:00 EDT
Brean Capital Downgrades Endocyte To Hold
Today 8:34 EDT
Brean Capital Downgrades Endocyte (ECYT) to Hold
Today 6:45 EDT
Cancer drug stocks on the move amid striking data
September 29, 2014
category Bristol/Myers Squibb Co , ARIAD Pharmaceuticals Inc , Health Care/Pharmaceuticals Biotechnology and Life Sciences , and 8 more.
from CNBC.com News
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here